Authors:
Ohe, Y
Niho, S
Kakinuma, R
Kubota, K
Matsumoto, T
Ohmatsu, H
Goto, K
Kunitoh, H
Saijo, N
Nishiwaki, Y
Citation: Y. Ohe et al., Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients, JPN J CLIN, 31(3), 2001, pp. 100-106
Authors:
Kunitoh, H
Akiyama, Y
Kusaba, H
Yamamoto, N
Sekine, I
Ohe, Y
Kubota, K
Tamura, T
Shinkai, T
Kodama, T
Goto, K
Niho, S
Nishiwaki, Y
Saijo, N
Citation: H. Kunitoh et al., A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 259-265
Authors:
Niho, S
Nishiwaki, Y
Goto, K
Ohmatsu, H
Matsumoto, T
Hojo, F
Ohe, Y
Kakinuma, R
Kodama, T
Citation: S. Niho et al., Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen, LUNG CANC, 27(3), 2000, pp. 159-167
Authors:
Hosomi, Y
Ohe, Y
Mito, K
Uramoto, H
Moriyama, E
Tanaka, K
Kodama, K
Niho, S
Goto, K
Ohmatsu, H
Matsumoto, T
Hojo, F
Kakinuma, R
Nishiwaka, Y
Citation: Y. Hosomi et al., Phase I study of cisplatin and docetaxel plus mitomycin C in patients withmetastatic non-small cell lung cancer, JPN J CLIN, 29(11), 1999, pp. 546-549
Citation: S. Niho et al., Immunohistochemical and clonal analysis of minute pulmonary meningothelial-like nodules, HUMAN PATH, 30(4), 1999, pp. 425-429